A Study in Patients With Mild or Moderate Ulcerative Colitis Who Take a TNF Inhibitor. The Study Investigates Whether Bowel Inflammation Improves When Patients Take BI 655130 in Addition to Their Current Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 7, 2017

Primary Completion Date

March 26, 2020

Study Completion Date

September 16, 2020

Conditions
Colitis, Ulcerative
Interventions
DRUG

Spesolimab

12 weeks treatment

DRUG

Placebo

12 weeks treatment

Trial Locations (16)

2730

Sanos Clinic, Herlev

5000

Odense University Hospital, Odense

9100

Aalborg Sygehus Syd, Aalborg

24105

Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel

28222

Hospital Puerta de Hierro, Majadahonda

30625

Medizinische Hochschule Hannover, Hanover

39008

Hospital Universitario Marqués de Valdecilla, Santander

46026

Hospital Politècnic La Fe, Valencia

79106

Universitätsklinikum Freiburg, Freiburg im Breisgau

89081

Universitätsklinikum Ulm, Ulm

91054

Universitätsklinikum Erlangen, Erlangen

1105 AZ

Amsterdam UMC, Locatie AMC, Amsterdam

N-1478

Akershus Universitetssykehus HF, Lørenskog

LS9 7TF

St James's University Hospital, Leeds

SE1 9RT

Guy's Hospital, London

L35 5DR

Whiston Hospital, Prescot

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY